Conference Coverage

New BACE1 study launches in the shadow of verubecestat’s demise

Publish date: November 4, 2017

 

AT CTAD

On Twitter @Alz_Gal

Pages

Recommended Reading

Fueling the Alzheimer’s brain with fat
MDedge Psychiatry
Study linked H2 receptor antagonists, but not PPIs, to dementia
MDedge Psychiatry
Higher BP targets suggested for elderly, cognitively impaired
MDedge Psychiatry
Personality changes may not occur before Alzheimer’s onset
MDedge Psychiatry
APOE affects tau pathology independent of amyloid-beta
MDedge Psychiatry
VIDEO: Alzheimer’s blood test expected soon
MDedge Psychiatry
Lumateperone shows broad phase 3 potential for psychiatric disorders
MDedge Psychiatry
Analysis of failed Alzheimer’s trials gives two antiamyloid antibodies new momentum
MDedge Psychiatry
In Lewy body disease, CSF may reveal dementia risk
MDedge Psychiatry
Aducanumab continues to rack up positive numbers in phase 1b open-label extension
MDedge Psychiatry